227 related articles for article (PubMed ID: 28099443)
1. Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.
Chedik L; Bruyere A; Le Vee M; Stieger B; Denizot C; Parmentier Y; Potin S; Fardel O
PLoS One; 2017; 12(1):e0169480. PubMed ID: 28099443
[TBL] [Abstract][Full Text] [Related]
2. Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters.
Chedik L; Bruyere A; Fardel O
Xenobiotica; 2019 Mar; 49(3):363-374. PubMed ID: 29448871
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.
Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O
PLoS One; 2015; 10(3):e0121232. PubMed ID: 25803276
[TBL] [Abstract][Full Text] [Related]
4. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
Bucher S; Le Vee M; Jouan E; Fardel O
J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.
Mayati A; Bruyere A; Moreau A; Jouan E; Denizot C; Parmentier Y; Fardel O
PLoS One; 2015; 10(12):e0144667. PubMed ID: 26657401
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors.
Kerhoas M; Le Vée M; Carteret J; Jouan E; Tastet V; Bruyère A; Huc L; Fardel O
Chemosphere; 2024 Jun; 358():142122. PubMed ID: 38663675
[TBL] [Abstract][Full Text] [Related]
8. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
Ebner T; Ishiguro N; Taub ME
J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
[TBL] [Abstract][Full Text] [Related]
9. Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Rizk ML; Houle R; Chan GH; Hafey M; Rhee EG; Chu X
Antimicrob Agents Chemother; 2014; 58(3):1294-301. PubMed ID: 24295974
[TBL] [Abstract][Full Text] [Related]
10. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
11. Interactions of bilastine, a new oral H₁ antihistamine, with human transporter systems.
Lucero ML; Gonzalo A; Ganza A; Leal N; Soengas I; Ioja E; Gedey S; Jahic M; Bednarczyk D
Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():8-17. PubMed ID: 22616811
[TBL] [Abstract][Full Text] [Related]
12. Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Yu RZ; Warren MS; Watanabe T; Nichols B; Jahic M; Huang J; Burkey J; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Apr; 26(2):111-7. PubMed ID: 26959999
[TBL] [Abstract][Full Text] [Related]
13. Differential interactions of carbamate pesticides with drug transporters.
Guéniche N; Bruyere A; Ringeval M; Jouan E; Huguet A; Le Hégarat L; Fardel O
Xenobiotica; 2020 Nov; 50(11):1380-1392. PubMed ID: 32421406
[TBL] [Abstract][Full Text] [Related]
14. Preclinical assessment of drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin αvβ3 antagonist.
Fujioka K; Fekry MI; Rumsey JM; Steiner T; Thompson D; Mousa SA
Clin Transl Sci; 2023 Jun; 16(6):987-1001. PubMed ID: 36967488
[TBL] [Abstract][Full Text] [Related]
15. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
16. Neonicotinoid pesticides poorly interact with human drug transporters.
Le Vée M; Bacle A; Bruyere A; Fardel O
J Biochem Mol Toxicol; 2019 Oct; 33(10):e22379. PubMed ID: 31364238
[TBL] [Abstract][Full Text] [Related]
17. Differential
Bruyère A; Le Vée M; Jouan E; Molez S; Nies AT; Fardel O
Xenobiotica; 2021 Apr; 51(4):467-478. PubMed ID: 33455503
[TBL] [Abstract][Full Text] [Related]
18. Transporter-mediated Natural Product-Drug Interactions.
Bi Y; Wang X; Ding H; He F; Han L; Zhang Y
Planta Med; 2023 Feb; 89(2):119-133. PubMed ID: 35304735
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
20. The Effects of Drug Metabolizing Enzyme Inhibitors on Hepatic Efflux and Uptake Transporters.
Cheong J; Halladay JS; Plise E; Sodhi JK; Salphati L
Drug Metab Lett; 2017; 11(2):111-118. PubMed ID: 29032766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]